Discounted Cash Flow
Medtronic Plc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
| Dividends | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | — | $3.5b | $-188.0m | — | $2.51 |
| 2017 | — | $4.0b (13.8%) | $2.5b (1434.6%) | — | $2.92 (16.3%) |
| 2018 | — | $3.1b (-22.9%) | $1.5b (-40.9%) | — | $2.29 (-21.6%) |
| 2019 | — | $4.6b (49.2%) | $4.5b (201.5%) | — | $3.44 (50.2%) |
| 2020 | — | $4.8b (3.4%) | $-3.8b (-185.0%) | — | $3.57 (3.8%) |
| 2021 | — | $3.6b (-24.7%) | $-5.6b (-46.3%) | — | $2.68 (-24.9%) |
| 2022 | — | $5.0b (39.7%) | $-2.5b (54.5%) | — | $3.75 (39.9%) |
| 2023 | — | $3.8b (-25.4%) | $-1.5b (41.8%) | — | $2.83 (-24.5%) |
| 2024 | — | $3.7b (-2.2%) | $-961.0m (34.8%) | — | $2.77 (-2.1%) |
| 2025 | — | $4.7b (26.8%) | $-1.2b (-23.0%) | — | $3.63 (31.0%) |
| 2026 | — | $4.8b (3.0%) | $-1.4b (-18.0%) | — | $3.75 (3.3%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.